TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
ELTX

Elicio Therapeutics Inc.

Healthcare · Biotechnology

1.90$ -2.1% vs. previous close Closing price · As of: Oct 6, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement ELTX
Line item 2012 2013 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% – – – –
50.3% 48.2% 9.4% 76.4% 63.1% 4.4% – – – –
49.7% 51.8% 90.6% 23.6% 36.9% 95.6% – – – –
– 3.0% 227.1% 2,003.2% 1,350.0% 171.7% – – – –
– – – 188.2% 104.2% 26.6% – – – –
55.4% 57.8% 446.5% 2,618.8% 1,956.1% 234.5% – – – –
-5.7% -6.0% -356.0% -2,595.2% -1,919.2% -138.8% – – – –
4.2% 4.6% – – 307.2% 3.1% – – – –
16.4% 26.3% -497.0% -2,734.2% -2,781.5% -192.8% – – – –
2.8% 6.9% – 5.5% 0.3% 3.1% – – – –
4.2% 9.6% -497.0% -2,734.2% -2,781.5% -93.2% – – – –
26.9% 1.0% -355.9% -2,700.9% -2,452.5% -183.4% – – – –

Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?